Momeneh Foroutan
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Circulating tumor cell-derived lines exhibit an amoeboid mode of migration.
Journal: Scientific reports
Published: October 27, 2025
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling.
Journal: Cancer cell
Published: November 01, 2024
DOT1L maintains NK cell phenotype and function for optimal tumor control.
Journal: Cell reports
Published: November 06, 2023
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 20, 2023
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.
Journal: Clinical epigenetics
Published: November 22, 2022
A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients.
Journal: Frontiers in immunology
Published: August 04, 2022
Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.
Journal: Cancers
Published: April 11, 2022
Removing unwanted variation from large-scale RNA sequencing data with PRPS.
Journal: Nature biotechnology
Published: February 19, 2022
TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity.
Journal: Cancer immunology research
Published: December 07, 2021
Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.
Journal: Cancer immunology research
Published: July 20, 2021
The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome.
Journal: Cancer immunology research
Published: February 19, 2021
Last Updated: 09/26/2026